Tan Boon Toh

3.0k total citations · 1 hit paper
40 papers, 1.9k citations indexed

About

Tan Boon Toh is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Tan Boon Toh has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Tan Boon Toh's work include Cancer Cells and Metastasis (7 papers), Protein Degradation and Inhibitors (6 papers) and Glioma Diagnosis and Treatment (5 papers). Tan Boon Toh is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Protein Degradation and Inhibitors (6 papers) and Glioma Diagnosis and Treatment (5 papers). Tan Boon Toh collaborates with scholars based in Singapore, United States and China. Tan Boon Toh's co-authors include Edward Kai‐Hua Chow, Jhin Jieh Lim, Lissa Hooi, Lissa Nurrul Abdullah, Dean Ho, Mengjie Gu, Weixin Hou, Masturah Bte Mohd Abdul Rashid, Eliza Li Shan Fong and Xin Wang and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Tan Boon Toh

40 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondria-Targeting Type-I Photodrug: Harnessing Caspase-3 Activity for Pyroptotic Oncotherapy

2024 67 citations Zhigao Yi, Li Zhang et al. Journal of the American Chemical Society profile →

Peers

Countries citing papers authored by Tan Boon Toh

Since Specialization

Citations

This map shows the geographic impact of Tan Boon Toh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tan Boon Toh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tan Boon Toh more than expected).

Fields of papers citing papers by Tan Boon Toh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tan Boon Toh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tan Boon Toh. The network helps show where Tan Boon Toh may publish in the future.

Co-authorship network of co-authors of Tan Boon Toh

This figure shows the co-authorship network connecting the top 25 collaborators of Tan Boon Toh. A scholar is included among the top collaborators of Tan Boon Toh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tan Boon Toh. Tan Boon Toh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mitochondria-Targeting Type-I Photodrug: Harnessing Caspase-3 Activity for Pyroptotic Oncotherapy breakdown → 2024 ·Journal of the American Chemical Society ·Zhigao Yi, (unknown), Li Zhang, Huan Chen, (unknown), Zichao Luo, Tao Wang, (unknown), Yelin Wu, Tan Boon Toh, Chun‐Sing Lee, Wenbo Bu, Xiaogang Liu	67
2	Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review 2024 ·Experimental Hematology and Oncology ·Yating Shen, (unknown), Andrea Li Ann Wong, Tan Boon Toh	10
3	Biomarkers for immune checkpoint inhibition in sarcomas – are we close to clinical implementation? 2023 ·Biomarker Research ·(unknown), (unknown), Vivian Lim, Tan Boon Toh, Valerie Shiwen Yang	19
4	Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment 2022 ·Biomaterials ·(unknown), (unknown), (unknown), (unknown), (unknown), Lissa Hooi, Touati Benoukraf, Pierce K. H. Chow, Yock Young Dan, Edward Kai‐Hua Chow, Tan Boon Toh, Eliza Li Shan Fong	62
5	Three-Dimensional Macroporous Sponge for the Culture of Hepatocellular Carcinoma Patient-Derived Xenograft Organoids 2021 ·SLAS TECHNOLOGY ·Tan Boon Toh, (unknown), Hanry Yu, Eliza Li Shan Fong	4
6	Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity 2019 ·Angewandte Chemie International Edition ·Maria V. Babak, Zhi Yang, Bertrand Czarny, Tan Boon Toh, Lissa Hooi, Edward Kai‐Hua Chow, Wee Han Ang, Dan Gibson, Giorgia Pastorin	95
7	Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity 2019 ·Angewandte Chemie ·Maria V. Babak, Zhi Yang, Bertrand Czarny, Tan Boon Toh, Lissa Hooi, Edward Kai‐Hua Chow, Wee Han Ang, Dan Gibson, Giorgia Pastorin	27
8	Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma 2019 ·Journal of Hepatology ·Tan Boon Toh, Jhin Jieh Lim, Lissa Hooi, Masturah Bte Mohd Abdul Rashid, Edward Kai‐Hua Chow	97
9	Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP) 2018 ·Science Translational Medicine ·Masturah Bte Mohd Abdul Rashid, Tan Boon Toh, Lissa Hooi, Aleidy Silva, Yanzhou Zhang, Pei Fang Tan, Ai Ling Teh, Neerja Karnani, Sudhakar Jha, Chih‐Ming Ho, Wee Joo Chng, Dean Ho, Edward Kai‐Hua Chow	84
10	Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer 2018 ·Biomaterials ·Eliza Li Shan Fong, Tan Boon Toh, Quy Xiao Xuan Lin, Zheng Liu, Lissa Hooi, Masturah Bte Mohd Abdul Rashid, Touati Benoukraf, Edward Kai‐Hua Chow, Hung Huynh, Hanry Yu	55
11	Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel 2018 ·Data in Brief ·Eliza Li Shan Fong, Tan Boon Toh, Quy Xiao Xuan Lin, Zheng Liu, Lissa Hooi, Masturah Bte Mohd Abdul Rashid, Touati Benoukraf, Edward Kai‐Hua Chow, Hung Huynh, Hanry Yu	4
12	Stimuli-Responsive Nanodiamond-Based Biosensor for Enhanced Metastatic Tumor Site Detection 2017 ·SLAS TECHNOLOGY ·Xin Wang, Mengjie Gu, Tan Boon Toh, (unknown), Edward Kai‐Hua Chow	36
13	Epigenetics in cancer stem cells 2017 ·Molecular Cancer ·Tan Boon Toh, Jhin Jieh Lim, Edward Kai‐Hua Chow	310
14	Applications of stimuli-responsive nanoscale drug delivery systems in translational research 2017 ·Drug Discovery Today ·Mengjie Gu, Xin Wang, Tan Boon Toh, Edward Kai‐Hua Chow	79
15	3D Culture as a Clinically Relevant Model for Personalized Medicine 2017 ·SLAS TECHNOLOGY ·Eliza Li Shan Fong, Tan Boon Toh, Hanry Yu, Edward Kai‐Hua Chow	49
16	TIP60 inhibits metastasis by ablating DNMT1−SNAIL2-driven epithelial-mesenchymal transition program 2016 ·Journal of Molecular Cell Biology ·Yanzhou Zhang, Sudhir Krishna, Deepa Rajagopalan, Cheng Yong Tham, Lissa Nurrul Abdullah, Tan Boon Toh, Min Gong, Tuan Zea Tan, (unknown), Amit Kumar Pandey, Neerja Karnani, Edward Kai‐Hua Chow, Jean Paul Thiery, Sudhakar Jha	16
17	Nanodiamond–Manganese dual mode MRI contrast agents for enhanced liver tumor detection 2016 ·Nanomedicine Nanotechnology Biology and Medicine ·Weixin Hou, Tan Boon Toh, Lissa Nurrul Abdullah, (unknown), Kuan J. Lee, Ilonka Guenther, Edward Kai‐Hua Chow	51
18	A Distinct Reactive Oxygen Species Profile Confers Chemoresistance in Glioma-Propagating Cells and Associates with Patient Survival Outcome 2013 ·Antioxidants and Redox Signaling ·(unknown), (unknown), (unknown), Tan Boon Toh, Edwin Sandanaraj, Yuk Kien Chong, (unknown), Greg Tucker‐Kellogg, Oi Lian Kon, Wai Hoe Ng, (unknown), Marie‐Véronique Clement, Shazib Pervaiz, Beng Ti Ang, Carol Tang	23
19	Progenitor-like Traits Contribute to Patient Survival and Prognosis in Oligodendroglial Tumors 2012 ·Clinical Cancer Research ·(unknown), Tan Boon Toh, (unknown), (unknown), Edwin Sandanaraj, (unknown), Swee Seong Wong, Siew Hong Leong, Oi Lian Kon, Greg Tucker‐Kellogg, Wai Hoe Ng, Ivan Ng, Carol Tang, Beng Ti Ang	12
20	Antioxidants: Promising neuroprotection against cardiotoxin-4b-induced cell death which triggers oxidative stress with early calpain activation 2007 ·Toxicon ·Tan Boon Toh, Minghui Jessica Chen, Arunmozhiarasi Armugam, (unknown), Qiu‐Tian Li, Kandiah Jeyaseelan, Nam Sang Cheung	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact